Abstract
Budd-Chiari syndrome occurs when venous outflow from the liver is obstructed. The obstruction may occur at any point from the hepatic venules to the left atrium. The syndrome most often occurs in patients with underlying thrombotic disorders such as polycythemia rubra vera, paroxysmal nocturnal hemoglobinuria and pregnancy. It may also occur secondary to a variety of tumours, chronic inflammatory diseases and infections. Imaging plays an important role both in establishing the diagnosis of Budd-Chiari syndrome as well as evaluating for underlying causes and complications such as portal hypertension. In this review article, we discuss the role of modern imaging in the evaluation of Budd-Chiari syndrome.
Similar content being viewed by others
References
Budd G (1845) On diseases of the liver. John Churchill, London, p 146
Chiari H (1899) Ueber die selbstandige phlebitis obliterans der huaptstamme der venae hepaticae als todesurache. Beitr Pathol Anat Allg Pathol 26:1–18
Kim TK, Chung JW, Han JK et al (1999) Hepatic changes in benign obstruction of the hepatic inferior vena cava: CT findings. AJR Am J Roentgenol 173:1235–1242
Espinosa G, Font J, Garcia-Pagan JC et al (2001) Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore) 80:345–354
Simsek S, Verheesen RV, Haagsma EB, Lourens J (2000) Subacute Budd-Chiari syndrome associated with polycythemia vera and factor V Leiden mutation. Neth J Med 57:62–67
Narayanan Menon KV, Shah V, Kamath PS (2004) The Budd-Chiari syndrome. New Engl J Med 350:578–585
Denninger MH, Chait Y, Casadevall N et al (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587–591
Minnema MC, Janssen HL, Niermeijer P, de Man RA (2000) Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J Hepatol 33:509–512
Bayraktar Y, Egesel T, Saglam F et al (1998) Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma? J Clin Gastroenterol 27:67–71
Singh V, Sinha SK, Nain CK et al (2000) Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 15:550–554
Asherson RA, Khamashta MA, Hughes GR (1991) The hepatic complications of the antiphospholipid antibodies. Clin Exp Rheumatol 9:341–344
Dilawari JB, Bambery P, Chawla Y et al (1994) Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 73:21–36
Karadag O, Akinci D, Aksoy DY (2005) Acute Budd-Chiari syndrome resulting from a pyogenic liver abscess. Hepatogastroenterology 52:1554–1613
Janssen HL, Garcia-Pagan JC, Elias E (2003) Budd-Chiari syndrome: a review by an expert panel. J Hepatol 38:364–371
Klein AS, Sitzmann JV, Coleman J et al (1990) Current management of the Budd-Chiari syndrome. Ann Surg 212:144–149
Faust TW (1999) Budd-Chiari syndrome. Curr Treat Options Gastroenterol 2:491–504
Bogin V, Marcos A, Shaw-Stiffel T (2005) Budd-Chiari syndrome: in evolution. Eur J Gastroenterol Hepatol 17:33–35
Boitnott JK, Kaufman S et al (1982) Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) 61:199–218
Valla DC (2003) The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 38:793–803
Chawla Y, Kumar S, Dhiman RK et al (1999) Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 14:904–907
Mahmoud AE, Mendoza A, Meshikhes AN et al (1996) Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM 89:37–43
McKusick MA (2001) Imaging findings in Budd-Chiari syndrome. Liver Transpl 7:743–744
Lin J, Chen XH, Zhou KR (2003) Budd-Chiari syndrome: diagnosis with three-dimensional contrast-enhanced magnetic resonance angiography. World J Gastroenterol 9:2317–2321
Noone TC, Semelka RC, Siegelman ES, Balci NC, Hussain SM, Kim PN, Mitchell DG (2000) Budd-Chiari syndrome: spectrum of appearances of acute, subacute, and chronicdisease with magnetic resonance imaging. J Magn Reson Imaging 11(1):44–50, Jan
Bahar K, Karayalcin S, Kaya M (2002) Percutaneous transhepatic venoplasty: an alternative treatment for Budd-Chiari syndrome. Turk J Gastroenterol 13:83–88
Khuroo MS, Al-Suhabani H, Al-Sebayel M (2005) Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 20:1494–1502
Abujudeh H, Contractor D, Delatorre A (2005) Rescue TIPS in acute Budd-Chiari syndrome. AJR Am J Roentgenol 185:89–91
Klein AS, Molmenti EP (2003) Surgical treatment of Budd-Chiari syndrome. Liver Transpl 9:891–896
Kohli V, Pande GK, Dev V et al (1993) Management of hepatic venous outflow obstruction. Lancet 342:718–722
Fisher NC, McCafferty I, Dolapci M et al (1999) Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44:568–574
Ganger DR, Klapman JB, McDonald V et al (1999) Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol 94:603–608
Avenhaus W, Ullerich H, Menzel J et al (1999) Budd-Chiari syndrome in a patient with factor V Leiden-successful treatment by TIPSS placement followed by liver transplantation. Z Gastroenterol 37:277–281
Blokzijl H, de Knegt RJ (2002) Long-term effect of treatment of acute Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt. Hepatology 35:1551–1552
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buckley, O., O’ Brien, J., Snow, A. et al. Imaging of Budd-Chiari syndrome. Eur Radiol 17, 2071–2078 (2007). https://doi.org/10.1007/s00330-006-0537-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-006-0537-2